Article info

Download PDFPDF
A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy

Authors

  1. Correspondence to Seiji Mabuchi, Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan; smabuchi{at}gyne.med.osaka-u.ac.jp
View Full Text

Citation

Mabuchi S, Yokoi E, Shimura K, et al
A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy

Publication history

  • Received August 25, 2018
  • Revision received October 25, 2018
  • Accepted November 2, 2018
  • First published January 4, 2019.
Online issue publication 
March 04, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.